Back to Search
Start Over
Vaccine response after pneumococcal vaccination in allogeneic hematopoietic stem cell transplant recipients.
- Source :
-
Journal of Oncology Pharmacy Practice . Jan2024, Vol. 30 Issue 1, p15-18. 4p. - Publication Year :
- 2024
-
Abstract
- Current guidelines for vaccination in allogeneic hematopoietic stem cell transplant (HCT) recipients recommend initiation of pneumococcal vaccination series three to six months post-HCT, with most data supporting initiation at six months due to a more robust immune response. This single-center, retrospective, observational chart review aimed to evaluate the impact of initiating the pneumococcal vaccine series at three months post-HCT compared to six months post-HCT. The primary endpoints were defined as a percentage of patients with a serologic response of >1 and >1.3 µg/mL for over 50% of the defined serotypes. Outcomes showed no difference in immunologic response between the two groups. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10781552
- Volume :
- 30
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Journal of Oncology Pharmacy Practice
- Publication Type :
- Academic Journal
- Accession number :
- 174972713
- Full Text :
- https://doi.org/10.1177/10781552231165733